The groundbreaking rise of Viagra has long been a example of pharmaceutical success, but its future within the broader industry now raises questions about long-term yields . Generic versions are eroding patent protection , causing worries that betting on companies closely tied to Viagra's once-dominant influence could be a dangerous move , especial